North Bridge: Lyra Therapeutics Raises $29.5M in Series B Financing
Lyra Therapeutics, Inc. (fka 480 Biomedical, Inc.), a Watertown, Mass.-based clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, raised $29.5m in Series B equity financing.
Read full article »
North Bridge is a private equity firm that focuses on investing in early-stage software development companies.
Read more